206 related articles for article (PubMed ID: 30796899)
1. Composition of plasmalogens in serum lipoproteins from patients with non-alcoholic steatohepatitis and their susceptibility to oxidation.
Ikuta A; Sakurai T; Nishimukai M; Takahashi Y; Nagasaka A; Hui SP; Hara H; Chiba H
Clin Chim Acta; 2019 Jun; 493():1-7. PubMed ID: 30796899
[TBL] [Abstract][Full Text] [Related]
2. Plasmalogen oxidation in human serum lipoproteins.
Felde R; Spiteller G
Chem Phys Lipids; 1995 Jun; 76(2):259-67. PubMed ID: 7634364
[TBL] [Abstract][Full Text] [Related]
3. Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis in mice.
Jang JE; Park HS; Yoo HJ; Baek IJ; Yoon JE; Ko MS; Kim AR; Kim HS; Park HS; Lee SE; Kim SW; Kim SJ; Leem J; Kang YM; Jung MK; Pack CG; Kim CJ; Sung CO; Lee IK; Park JY; Fernández-Checa JC; Koh EH; Lee KU
Hepatology; 2017 Aug; 66(2):416-431. PubMed ID: 28073164
[TBL] [Abstract][Full Text] [Related]
4. Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens.
Jürgens G; Fell A; Ledinski G; Chen Q; Paltauf F
Chem Phys Lipids; 1995 Aug; 77(1):25-31. PubMed ID: 7586089
[TBL] [Abstract][Full Text] [Related]
5. Proportion of nervonic acid in serum lipids is associated with serum plasmalogen levels and metabolic syndrome.
Yamazaki Y; Kondo K; Maeba R; Nishimukai M; Nezu T; Hara H
J Oleo Sci; 2014; 63(5):527-37. PubMed ID: 24770479
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of fluorescent glycero- and sphingophospholipids in human plasma lipoproteins: alkenylacyl subclasses are preferred targets.
Hofer G; Lichtenberg D; Kostner GM; Hermetter A
Clin Biochem; 1996 Oct; 29(5):445-50. PubMed ID: 8884065
[TBL] [Abstract][Full Text] [Related]
7. Lipoproteins secreted by cultured rat hepatocytes contain the antioxidant 1-alk-1-enyl-2-acylglycerophosphoethanolamine.
Vance JE
Biochim Biophys Acta; 1990 Jul; 1045(2):128-34. PubMed ID: 2116174
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylcholine and phosphatidylethanolamine plasmalogens in lipid loaded human macrophages.
Wallner S; Orsó E; Grandl M; Konovalova T; Liebisch G; Schmitz G
PLoS One; 2018; 13(10):e0205706. PubMed ID: 30308051
[TBL] [Abstract][Full Text] [Related]
9. Polyunsaturated fatty acid incorporation into plasmalogens in plasma membrane of glioma cells is preceded temporally by acylation in microsomes.
Thomas SE; Morris SJ; Xu Z; Byers DM; Palmer FB; Spence MW; Cook HW
Biochim Biophys Acta; 1992 Jun; 1126(2):125-34. PubMed ID: 1627614
[TBL] [Abstract][Full Text] [Related]
10. Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis.
Lessig J; Fuchs B
Curr Med Chem; 2009; 16(16):2021-41. PubMed ID: 19519379
[TBL] [Abstract][Full Text] [Related]
11. Role of plasmalogens in the enhanced resistance of LDL to copper-induced oxidation after LDL apheresis.
Hahnel D; Thiery J; Brosche T; Engelmann B
Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2431-8. PubMed ID: 10521373
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic absorption of choline plasmalogen is much higher than that of ethanolamine plasmalogen in rats.
Nishimukai M; Yamashita M; Watanabe Y; Yamazaki Y; Nezu T; Maeba R; Hara H
Eur J Nutr; 2011 Sep; 50(6):427-36. PubMed ID: 21152926
[TBL] [Abstract][Full Text] [Related]
13. Free radical oxidation of plasmalogen glycerophosphocholine containing esterified docosahexaenoic acid: structure determination by mass spectrometry.
Zemski Berry KA; Murphy RC
Antioxid Redox Signal; 2005; 7(1-2):157-69. PubMed ID: 15650405
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of plasmenyl glycerophosphoethanolamine lipids containing arachidonate to oxidative degradation.
Khaselev N; Murphy RC
Free Radic Biol Med; 1999 Feb; 26(3-4):275-84. PubMed ID: 9895217
[TBL] [Abstract][Full Text] [Related]
15. Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging.
Maeba R; Maeda T; Kinoshita M; Takao K; Takenaka H; Kusano J; Yoshimura N; Takeoka Y; Yasuda D; Okazaki T; Teramoto T
J Atheroscler Thromb; 2007 Feb; 14(1):12-8. PubMed ID: 17332687
[TBL] [Abstract][Full Text] [Related]
16. Plasmalogens: targets for oxidants and major lipophilic antioxidants.
Engelmann B
Biochem Soc Trans; 2004 Feb; 32(Pt 1):147-50. PubMed ID: 14748736
[TBL] [Abstract][Full Text] [Related]
17. Association of cholesterol efflux capacity with plasmalogen levels of high-density lipoprotein: A cross-sectional study in chronic kidney disease patients.
Maeba R; Kojima KI; Nagura M; Komori A; Nishimukai M; Okazaki T; Uchida S
Atherosclerosis; 2018 Mar; 270():102-109. PubMed ID: 29407877
[TBL] [Abstract][Full Text] [Related]
18. Analytical methods for (oxidized) plasmalogens: Methodological aspects and applications.
Fuchs B
Free Radic Res; 2015 May; 49(5):599-617. PubMed ID: 25536419
[TBL] [Abstract][Full Text] [Related]
19. Plasmalogen phospholipid hydrolysis during hypoxic injury of rabbit proximal tubules.
Portilla D; Creer MH
Kidney Int; 1995 Apr; 47(4):1087-94. PubMed ID: 7783405
[TBL] [Abstract][Full Text] [Related]
20. Serum choline plasmalogens-those with oleic acid in sn-2-are biomarkers for coronary artery disease.
Nishimukai M; Maeba R; Ikuta A; Asakawa N; Kamiya K; Yamada S; Yokota T; Sakakibara M; Tsutsui H; Sakurai T; Takahashi Y; Hui SP; Chiba H; Okazaki T; Hara H
Clin Chim Acta; 2014 Nov; 437():147-54. PubMed ID: 25068205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
